Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq Data of Liver Tissue and Tumors

ABSTRACT: RNA-seq Data of Liver Tissue and Tumors

PROVIDER: PRJNA1002234 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25516742_1.fastq.gz	Fastqsanger.gz
	SRR25516742_2.fastq.gz	Fastqsanger.gz
	SRR25516743_1.fastq.gz	Fastqsanger.gz
	SRR25516743_2.fastq.gz	Fastqsanger.gz
	SRR25516744_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 32

Similar Datasets

Expression data from ChREBP overexpressing HCC tumors compared to non-tumoral adjacent liver tissue

Project description:Expression data from ChREBP overexpressing HCC tumors compared to non-tumoral adjacent liver tissue

| PRJNA670028 | ENA

Expression data from murine liver and adipose tissue

Project description:Expression data from murine liver and adipose tissue

| PRJNA167959 | ENA

RNA-seq Data of Liver Tissue and Tumors

Project description:Oncogenic mutations accumulating in many chromatin-associated proteins have been identified in different tumor types. With a mutation rate from 10 to 57%, ARID1A has been widely considered a tumor suppressor gene. However, whether this role is mainly due to its transcriptional-related activities or its ability to preserve genome integrity is still a matter of intense debate. Here, we show that ARID1A is largely dispensable for preserving enhancer-dependent transcriptional regulation, being ARID1B sufficient and required to compensate for ARID1A loss. We provide in vivo evidence that ARID1A is mainly required to preserve genomic integrity in adult tissues. ARID1A loss primarily results in DNA damage accumulation, interferon type I response activation, and chronic inflammation leading to tumor formation. Our data suggest that in healthy tissues, the increased genomic instability that follows ARID1A mutations and the selective pressure imposed by the microenvironment might result in the emergence of aggressive, possibly immune-resistant, tumors.

2024-03-17 | GSE240067 | GEO

Expression data from ChREBP overexpressing HCC tumors compared to non-tumoral adjacent liver tissue

Project description:ChREBP was stably overexpressed in the liver of C57BL/6J mice through the use of the sleeping beauty transposon system. ChREBP overexpression resulted in HCC tumor development in 12 months. We used microarray analysis to detail the global program of gene expression in ChREBP overexpressing tumors compared to non-tumoral adjacent tissue or compared with normal liver samples from C57BL/6J mice. WE then identified distinct classes of up and down regulated genes.

2022-04-15 | GSE159518 | GEO

RNA-seq for liver tissue in mice

Project description:RNA-seq for liver tissue in mice

| PRJNA1103184 | ENA

RNA-seq of liver tissue and liver cancer cell lines

Project description:RNA-seq of liver tissue and liver cancer cell lines

| PRJEB11781 | ENA

Expression data from liver tissue of mice (Mus musculus)

Project description:Expression data from liver tissue of mice (Mus musculus)

| PRJNA493128 | ENA

Microarray expression data from FVB mice with induced hepatoblastoma (liver tumors)

Project description:Microarray expression data from FVB mice with induced hepatoblastoma (liver tumors)

| PRJNA447940 | ENA

RNA-seq of Liver Cancer

Project description:The French ICGC project on liver tumors is coordinated by Pr Jessica Zucman-Rossi and funded by Inca (French Institute for Cancer). The aim of the present project is to identify the catalog of somatic and germline mutations in liver tumors using whole genome (WGS) and whole exome sequencing (WGS), integrated with DNA methylation and RNA sequencing (RNA-seq) data. The present series corresponds to 161 RNA-seq samples from tumors with matched WES or WGS. Hepatocellular carcinoma (HCC) accounts for more than 90% of liver cancers, and is a major health problem. It is the 3rd cause of cancer-related mortality. Advances in genomic analyses have formed a comprehensive understanding of different underlying pathobiological layers resulting in hepatocarcinogenesis. Thus, the development of next-generation sequencing technologies has made it possible to generate more comprehensive catalogues of somatic alteration events (single nucleotide substitutions, structural variations, and epigenetic changes) in liver cancer genome than ever before.

| EGAS00001002879 | EGA

Murine HCC development: comparison of wt, krt18+/- and krt18-/- liver tumors hybridized against non-affected wt liver tissue

Project description:Analysis of the different genotype tumors revealed enhanced chromosomal aberrations in all tumors. The most chromosomal aberrations were found in the krt18-/- tumors. Two-condition experiment: wt (non-affected) liver tissue vs. wt tumor / krt18+/-tumor / krt18-/- tumor

2013-07-02 | E-GEOD-47212 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data